Occult GI bleeding in the alcoholic

American Journal of Gastroenterology

Volumn 91, Issue 3, 1996, Pages 551-553

  Zwas, Felice R ^a,b   Lyon, David T ^a,c  

^a LONG ISLAND COLLEGE HOSPITAL   (United States)

^b Center for Gastrointestinal Medicine   (United States)

^c Ellis Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALCOHOLISM; ARTICLE; CLINICAL ARTICLE; COLORECTAL TUMOR; DIGESTIVE TRACT ENDOSCOPY; EROSION; FEMALE; HUMAN; MALE; OCCULT BLOOD; PEPTIC ULCER; PRECANCER; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; ALCOHOLISM; COLONIC NEOPLASMS; ENDOSCOPY, GASTROINTESTINAL; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMANS; MALE; MIDDLE AGED; OCCULT BLOOD; PEPTIC ULCER HEMORRHAGE; PRECANCEROUS CONDITIONS; PREVALENCE;

EID: 0029863119     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Zwas FR, Lyon DT, Rosen DR. Clinical significance of fecal occult blood in the alcoholic. Am J Gastroenterol 1987;82:949.
2. Valliant GE. The natural history of alcoholism: Causes, patterns, and paths to recovery. Cambridge, MA: Harvard University Press, 1983.
3. MacMath TL. Alcohol and gastrointestinal bleeding. Emerg Med Clin North Am 1990;8:859-72.
4. Burbige EJ, Lewis DR, Jr, Halsted CH. Alcohol and the gastrointestinal tract. Med Clin North Am 1984;68:77-89.
5. Boyer TD. Portal hypertension and bleeding esophageal varices. In: Zakim D, Boyer TD, eds. Hepatology: A textbook of liver disease, 2nd ed. Philadelphia: WB Saunders, 1990: 572-615.
6. Gottfried EB, Korsten MA, Lieber CS. Gastritis and duodenitis induced by alcohol: An endoscopic and histologic assessment. Gastroenterology 1976;70:890.
7. Sarfeh IJ, Tabak C, Eugene J, et al. Clinical significance of erosive gastritis in patients with alcoholic liver disease and upper gastrointestinal hemorrhage. Ann Surg 1981;194:149-51.
8. Tarnawski A, Stachura J, Evey KJ, et al. Alcohol injury to the normal human gastric mucosa: Endoscopic, histologic and functional assessment. Clin Invest Med 1987;10:259-63.
9. Laine L, Weinstein WM. Histology of alcoholic hemorrhagic "gastritis": A prospective evaluation. Gastroenterology 1988;94:1254-62.
10. Groszmann RJ, Atterbury CE. The pathophysiology of portal hypertension. Semin Liver Dis 1982;2:177-86.
11. Krogsgaard K, Gluud C, Henriksen JH, et al. Correlation between liver morphology and portal pressure in alcoholic liver disease. Hepatology 1984;4:699-703.
12. Winawer SJ, Fleisher M. Sensitivity and specificity of the fecal occult blood test for colorectal neoplasia. Gastroenterology 1982;82:986-91.
13. Simon JB. Occult blood screening for colorectal carcinoma: A critical review. Gastroenterology 1985;88:820-37.
14. Kronborg O, Fenger C, Sondergaard O, et al. Initial mass screening for colorectal cancer with fecal occult blood test. Scand J Gastroenterol 1987;22:677-86.
15. Allison JE, Feldman R, Tekawa IS. Hemoccult screening in detecting colorectal neoplasm: Sensitivity, specificity and predictive value. Ann Intern Med 1990;112:328-33.
16. Eisner MS, Lewis JH. Diagnostic yield of a positive fecal occult blood test found on digital rectal examination. Arch Intern Med 1991;151: 2180-4.
17. Brint SL, Herrera JL, DiPalma JA. Is a Hemoccult positive rectal examination clinically significant? Am J Gastroenterol 1991;86:1351.
18. American Psychiatric Association. Diagnostic statistical manual of mental disorders, 3rd ed. Washington DC: American Psychiatric Association, 1987.
19. Uno Y, Munakata A. Endoscopic and histologic correlates of colorectal polyp bleeding. Gastrointest Endosc 1995;41:460-7.
20. Macrae FA, St. John JB. Relationship between patterns of bleeding and hemoccult sensitivity in patients with colorectal cancers or adenomas. Gastroenterology 1982;82:891-8.
21. Olden K, Robinson D. Occult blood loss in an alcoholic rehab population. Gastroenterology 1992;102:A22 (abstract).
22. Bahrt KM, Korman LY, Nashel DJ. Significance of a positive test for occult blood in stools of patients taking anti-inflammatory drugs. Arch Intern Med 1984;144:2165-6.
23. Pye G, Ballantyne KC, Armitage NC, et al. Influence of nonsteroidal anti-inflammatory drugs on the outcome of faecal occult blood tests in screening for colorectal cancer. Br Med J 1987;294:1510-1.
24. Winchester DP, Shull JH, Scanlow EF, et al. A mass screening program for colorectal cancer using chemical testing for occult blood in the stool. Cancer 1980;45:2955-8.
25. Hardcastle JD, Armitage NC, Chamberlain J, et al. Fecal occult blood screening for colorectal cancer in the general population: Results of a controlled trial. Cancer 1986;58:397-403.
26. Fleming JL, Ahlquist DA, McGill DB, et al. Influence of aspirin and ethanol on fecal blood levels as determined by using the HemoQuant assay. Mayo Clin Proc 1987;62:159-63.
27. Correa P. Epidemiology of polyps and cancer. In: Morson BC, ed. The pathogenesis of colorectal cancer. Philadelphia: WB Saunders, 1978: 126-52.
28. Schottenfeld D, Winawer SJ. Large intestine. In: Schottenfeld D, Fraumeni J, eds. Cancer epidemiology and prevention. Philadelphia: WB Saunders, 1982: 703-27.
29. Pollack ES, Nomura AMY, Heilbrun LK, et al. Prospective study of alcohol consumption and cancer. N Engl J Med 1984;310:617-21.
30. Vogel VG, McPherson RS. Dietary epidemiology of colon cancer. Hematol Oncol Clin North Am 1989;3:35-63.
31. Winawer SJ, Zauber AG, Ho MN, et al. Prevention of colorectal cancer by colonoscopic polypectomy. N Engl J Med 1993;329:1977-81.
32. Winawer SJ, Schottenfeld D, Flehinger BJ. Colorectal cancer screening. J Natl Cancer Inst 1991;83:243-53.